All Articles

Enfortumab Vedotin Promising Third-Line Option for Metastatic Urothelial Cancer After Checkpoint Inhibitor
Urothelial Cancer
December 2019 Vol 10, No 12
Patients with metastatic urothelial cancer receive first-line treatment with platinum-based chemotherapy and second-line treatment with a checkpoint inhibitor.
Read More
Conducting a Meaningful Community Needs Assessment
By Theresa A. Allen, OPN-CG
Establishing a Successful Navigation Program
December 2019 Vol 10, No 12
No need to reinvent the wheel, a community needs assessment will assist in filling gaps and reducing barriers to care.
Read More
The Sounds of Music
By Margaret Rummel, RN, MHA, OCN, NE-BC; Penny Daugherty, RN, OCN, ONN-CG
December 2019 Vol 10, No 12
As nurse navigators, our first encounter with a patient typically is at the point where they have been diagnosed with cancer.
Read More
How My Nurse Navigator Helped Me
How My Nurse Navigator Helped Me
By Kirsten Arbon
Video Library
2019 Hero of Hope Patient Award winner Kirsten Arbon explains how her nurse navigator provided her with guidance, wisdom, and support during her cancer journey.
Read More
Supporting Families with the KM3 Project
Supporting Families with the KM3 Project
By Kirsten Arbon
Video Library
2019 Hero of Hope Patient Award winner Kirsten Arbon discusses her non-profit, the KM3 Project, which provides financial support to patients with cancer who are parents of children under 18.
Read More
My Journey as an Expectant Mother Diagnosed with Cancer
My Journey as an Expectant Mother Diagnosed with Cancer
By Kirsten Arbon
Video Library
2019 Hero of Hope Patient Award winner Kirsten Arbon speaks about her experience of being treated for cancer while pregnant, and offers advice to survivors and their loved ones.
Read More
November 25, 2019 – Oncology News & Updates
By Yvette Florio Lane
FDA Updates, In the News, Leukemia & Lymphoma, Lung Cancer
Web Exclusives
  • Calquence Receives FDA Approval for the Treatment of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  • Despite Some Positive Trends, Report Confirms Lung Cancer Remains the Deadliest Form of Cancer
Read More
FDA Approves Adakveo to Reduce Vaso-Occlusive Crises in Patients with Sickle-Cell Disease
FDA Updates, In the News
Web Exclusives

On November 15, 2019, the FDA approved crizanlizumab (Adakveo; Novartis) to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged ≥16 years with sickle-cell disease.

Read More
November 18, 2019 — Oncology News & Updates
FDA Updates, Hepatocellular Carcinoma, In the News, Leukemia & Lymphoma
Web Exclusives
  • Teva Will Resume Production of Vincristine in Response to Shortage
  • FDA Fast-Tracks Opdivo plus Yervoy Regimen for Treatment of Advanced Liver Cancer
  • FDA Grants Accelerated Approval to Brukinsa for Patients with Mantle-Cell Lymphoma
Read More

Page 162 of 283

Journal of Oncology Navigation & Survivorship

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

Connect with Us

 
 
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.